Experimental Pill Nearly Doubles Survival in Pancreatic Cancer
A late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
Knowing when to start retirement discussions with a financial advisor can enhance your planning. Get the guidance you need to succeed.
20,658 articlesA late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
Investors are buzzing as SAIC reports stronger-than-expected results and a growing federal pipeline. This article bre...
State investigators are scrutinizing FIFA ticketing as dynamic pricing drives eye-popping costs and questions about s...
When a century-spanning blue-chip changes its share count, investors take notice. This article breaks down what a rev...
Victoria’s Secret defies doubters by ditching perpetual sales and a woke marketing tone, posting stronger-than-expect...
A high-profile CEO champions self-taught, AI-fluent leadership while leaning on a deep bench of scientists. The piece...
Reality TV figure Spencer Pratt publicly challenges Karen Bass, signaling a hard line on budget reform. The confronta...
As Anthropic prepares an IPO, history warns that sky-high private valuations rarely translate into smooth public-mark...
A private AI and spatial-computing company is drawing retail attention ahead of a potential IPO, with a reserved NASD...
Stellantis is betting big on a single brand to lift profits in North America. This strategic move centers on Ram and ...
AI-driven automation is reshaping tech hiring. While some roles shrink, new opportunities emerge in AI tooling, data ...
Insiders sold a meaningful block of stock at Select Water Solutions, yet the company still shows a strong growth stor...